The Society of Interventional Radiology

The vision to heal

SIR Learning Center

Extended care through advanced technology

Featured Activities

This month’s journal-based CME article is titled "Single-center comparison of overall survival and toxicities in patients with infiltrative HCC treated with Yttrium-90 Radioembolization or Drug-eluting embolic transarterial chemoembolization".

This single-center retrospective study evaluates the overall survival of patients with infiltrative HCC treated with Y-90 radioembolization and Drug-eluting embolics (DEE-TACE) or Yttrium-90.

To receive CME credit for this journal-based CME activity, participants must read the journal article and score 60% or better on the post test. Participants will have three opportunities to score 60% or better.

After participating in this journal-based CME activity, learners should be able to

  • List the 1-year survival rate after DEE-TACE for infiltrative HCC.
  • Recite th common symptons of post-procedural toxicity in patients treated with DEE-TACE.
  • Identify characteristics of infiltrative HCC that differ from other variety of HCCs.

This program is designed to meet the educational needs of interventional radiologists, hepatologists, oncologists, radiation-oncologists, hepato-biliary surgeons, nurses, techs, and trainees at all level with special interest in HCC.

JVIR CME Editor
Nishita Kothary, MD
Stanford University Medical Center, Stanford CA

Authors
Joseph L McDevitt, MD, MBA
Ali Alian, MD
Baljendra Kapoor, MD
Stacy Bennett, RN
Amanjit Gill, MD
Abraham Levitin, MD
Mark Sands, MD
KV Narayan Menon, MD
Federico N Aucejo, MD
Bassam Estfan, MD
Anil K Pillai, MD
Sanjeeva P Kalva, MD
Gordon McLennan, MD

University of Texas-Southwestern Medical Center, Radiology, Dallas, TX

This activity has been planned and implemented in accordance with the Essentials and Standards of the Accreditation Council for Continuing Medical Education (ACCME).

The Society of Interventional Radiology (SIR) is accredited by the ACCME to provide continuing medical education for physicians. SIR designates this education activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This program is approved for 1 self-assessment CME credit (SA-CME) by the Society of Interventional Radiology (SIR) - approved September 1, 2017. SIR is awarded Deemed Status by the American Board of Radiology (ABR). The SA-CME credit offered for this enduring activity meets the ABR’s criteria for self-assessment toward the purpose of fulfilling requirements in the ABR Maintenance of Certification (MOC) Program.

This month’s journal-based CME article is titled "Albumin-Bilirubin (ALBI) and Platelet-Albumin-Bilirubin (PALBI) Grade accurately predict overall survival in high-risk patients undergoing conventional Transarterial Chemoembolization for Hepatocellular Carcinoma".

This retrospective study evaluates the role of albumin-bilirubin (ALBI) and platelet-albumin-bilirubin (PABLI) grades in predicting overall survival in high-risk patients undergoing conventional transarterial chemoembolization (cTACE) for hepatocellular carcinoma (HCC).

To receive CME credit for this journal-based CME activity, participants must read the journal article and score 60% or better on the post test. Participants will have three opportunities to score 60% or better.

After participating in this journal-based CME activity, learners should be able to

  • Describe the factors that have been reported to increase the risk of complications following cTACE.
  • Cite the approximate median survival in patients with ALBI grades 1, 2 and 3 respectively.
  • Recognize the advantage of ALBI grades over Child Pugh (CP) score in patients undergoing cTACE for HCC.

This program is designed to meet the educational needs of interventional radiologists, hepatologists, oncologists, radiation-oncologists, hepato-biliary surgeons, nurses, techs, and trainees at all level with special interest in HCC.

JVIR CME Editor
Nishita Kothary, MD
Stanford University Medical Center, Stanford CA

Authors
Jan Hansmann, MD
Maximilian J Evers, BS
James T Bui, MD
Ryan P Lokken, MD, MPH
Andrew J Lipnik, MD
Ron Gaba, MD
Charles E Ray, MD, PhD

University of Illinois Hospital and Health Sciences System, Department of Radiology, Division of Interventional Radiology, Chicago, IL  60612

Financial Disclosures

Conflicts of Interest: The authors of this manuscript declare no relationships with any companies, whose products or services may be related to the subject matter of this article.

Disclosures: 

CME Editor:
Scientific Advisor, Siemens Healthcare
Consultant: Cook

The authors wish to acknowledge Hajwa Kim, MS, MA for her assistance and support with the statistical analysis for the study, and the Center for Clinical and Translational Science at the University of Illinois at Chicago. The project described was supported by the National Center for Advancing Translational Sciences, National Institutes of Health, through Grant UL1TR002003. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.

This activity has been planned and implemented in accordance with the Essentials and Standards of the Accreditation Council for Continuing Medical Education (ACCME).

The Society of Interventional Radiology (SIR) is accredited by the ACCME to provide continuing medical education for physicians. SIR designates this education activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This program is approved for 1 self-assessment CME credit (SA-CME) by the Society of Interventional Radiology (SIR) - approved August 1, 2017. SIR is awarded Deemed Status by the American Board of Radiology (ABR). The SA-CME credit offered for this enduring activity meets the ABR’s criteria for self-assessment toward the purpose of fulfilling requirements in the ABR Maintenance of Certification (MOC) Program.

This month’s journal-based CME article is titled "CT-Guided Bone Biopsies in Metastatic Casstration-Resistant Prostate Cancer: Factors Predictive of Maximum Tumor Yield".

This clinical study evaluates the success rate of CT-guided bone biopsies in metastic castration-resitant prostate cancer (mCRPC).

To receive CME credit for this journal-based CME activity, participants must read the journal article and score 60% or better on the post test. Participants will have three opportunities to score 60% or better.

FREE for SIR members
$20.00 nonmembers

After participating in this journal-based CME activity, learners should be able to

  • Describe the technical success rate of CT-guided bone biopsies based on histological confirmation.
  • State the percentage of patients in whom RNA can be isolated for sequencing purposes.
  • Recognize factors that impact the diagnostic yield of CT-guided bone biopsies.

This program is designed to meet the educational needs of interventional radiologists, urologists, oncologists, radiation-oncologists and nurses, techs, and trainees at all levels with special interest in prostate cancer.

JVIR CME Editor
Nishita Kothary, MD
Stanford University Medical Center, Stanford CA

Authors
Michael Holmes, MD
Erik Foss, MD
Gabby Joseph, PhD
Adam Foye, BS
Brooke Beckett, MD
Daria Motamedi, MD
Jack Yojngren, PhD
George V. Thomas, MD
Jiaoti Huang, MD
Rahul Aggarwal, MD
Joshi J. Alumkal, MD
Tomasz M. Beer, MD
Eric J. Small, MD
Thomas M. Link, MD, PhD

University of California-San Francisco, Department of Radiology and Biomedical Imaging, 513 Parnassus Avenue, S-261, San Francisco CA  94143-0628

Financial Disclosures

Conflicts of Interest: The authors of this manuscript declare no relationships with any companies, whose products or services may be related to the subject matter of this article.

Disclosures: 

CME Editor:
Scientific Advisor, Siemens Healthcare
Consultant: Cook

The study has received funding by the Stand Up To Cancer Dream Team award (SU2C-AACR-DT0812). This research grant is administered by the American Association for Cancer Research, the scientific partner of SU2C. Additional funding is from a Department of Defense Synergistic Idea Award (W81XWH-13-1-0420).

This activity has been planned and implemented in accordance with the Essentials and Standards of the Accreditation Council for Continuing Medical Education (ACCME).

The Society of Interventional Radiology (SIR) is accredited by the ACCME to provide continuing medical education for physicians. SIR designates this education activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This program is approved for 1 self-assessment CME credit (SA-CME) by the Society of Interventional Radiology (SIR) - approved July 1, 2017. SIR is awarded Deemed Status by the American Board of Radiology (ABR). The SA-CME credit offered for this enduring activity meets the ABR’s criteria for self-assessment toward the purpose of fulfilling requirements in the ABR Maintenance of Certification (MOC) Program.

This month’s journal-based CME article is titled "Endovascular Iliocaval Stent Reconstruction for Inferior Vena Cava Filter-Associated Iliocaval Thrombosis: Approach, Technical Success, Safety, and 2-Year Outcomes In 120 Patients".

This retrospective study describes the technical success, outcomes, and patency of iliocaval stent reconstruction for iliocaval thrombosis following IVC filter placement.

To receive CME credit for this journal-based CME activity, participants must read the journal article and score 60% or better on the post test. Participants will have three opportunities to score 60% or better.

FREE for SIR members
$20.00 nonmembers

After participating in this journal-based CME activity, learners should be able to

  • Describe the rate of clinical success at 6 months in patients who undergo iliocaval reconstruction
  • Describe the primary-assisted patency rate for the iliocaval reconstruction
  • List the complication rate in patients undergoing iliocaval stent reconstruction for iliocaval thrombosis following IVC filter placement

This program is designed to meet the educational needs of interventional radiologists, vascular surgeons, hematologists, internists and nurses, techs, and trainees at all levels with special interest in Iliocaval thrombosis.

JVIR CME Editor
Nishita Kothary, MD
Stanford University Medical Center, Stanford CA

Authors
Jeffrey Forris Beecham Chick, MD, MPH, DABR
Alexandra Jo, MD
J. Matthew Meadows, MD
Steven David Abramowitz, MD
Minhajuddin S. Khaja, MD, MBA
Kyle Cooper, MD
David M. Williams, MD, FSIR

University of Michigan Health System, Dept. of Radiology, Division of Vascular and Interventional Radiology, 1500 East Medical Center Drive, Ann Arbor, MI  48109

Financial Disclosures

There are no conflicts of interest.

Disclosures: 

CME Editor:
Scientific Advisor, Siemens Healthcare
Consultant: Cook

This activity has been planned and implemented in accordance with the Essentials and Standards of the Accreditation Council for Continuing Medical Education (ACCME).

The Society of Interventional Radiology (SIR) is accredited by the ACCME to provide continuing medical education for physicians. SIR designates this education activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This program is approved for 1 self-assessment CME credit (SA-CME) by the Society of Interventional Radiology (SIR) - approved June 1, 2017. SIR is awarded Deemed Status by the American Board of Radiology (ABR). The SA-CME credit offered for this enduring activity meets the ABR’s criteria for self-assessment toward the purpose of fulfilling requirements in the ABR Maintenance of Certification (MOC) Program.

This month’s journal-based CME article is titled "Analysis of the RENAL and mRENAL scores and the relative importance of their components in the prediction of complications and local progression after percutaneous renal cryoablation".

This clinical study evaluates if mRENAL score and its individual component have a superior predictive value compared to the RENAL score for prediction of complications and recurrence after percutaneous renal cryoablation.

To receive CME credit for this journal-based CME activity, participants must read the journal article and score 60% or better on the post test. Participants will have three opportunities to score 60% or better.

After participating in this journal-based CME activity, learners should be able to

  • List factors for calculating the mRENAL and the RENAL nephrometry scores
  • Identify the differences in criterion for calculating the mRENAL and the RENAL nephrometry scores
  • Identify factors associated with increased risk of complications
  • List the rate of subsequent recurrence after primary efficacy at 6 months

This program is designed to meet the educational needs of interventional radiologists, nephrologists, urologists, oncologists and nurses, techs, and trainees at all levels with special interest in renal cancer.

JVIR CME Editor
Nishita Kothary, MD
Stanford University Medical Center, Stanford CA

Authors
Yi Gao, PhD
Robert J Lewandowski, MD
Joseph L McDevitt, MD, MBA
Samdeep K Mouki, MD, MS
Albert A Nemcek, Jr., MD
Ann B Ragin, PhD
Riad Salem, MD, MBA
Kent T Sato, MD
Yu-Kai Su, MD

Northwestern University Feinberg School of Medicine, Dept. of Radiology, 676 N. St. Clair Street, Suite 800, Chicago, IL  60611

Financial Disclosures

There are no conflicts of interest.

Disclosures: 

CME Editor:
Scientific Advisor, Siemens Healthcare
Consultant: Cook

This activity has been planned and implemented in accordance with the Essentials and Standards of the Accreditation Council for Continuing Medical Education (ACCME).

The Society of Interventional Radiology (SIR) is accredited by the ACCME to provide continuing medical education for physicians. SIR designates this education activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This program is approved for 1 self-assessment CME credit (SA-CME) by the Society of Interventional Radiology (SIR) - approved May 1, 2017. SIR is awarded Deemed Status by the American Board of Radiology (ABR). The SA-CME credit offered for this enduring activity meets the ABR’s criteria for self-assessment toward the purpose of fulfilling requirements in the ABR Maintenance of Certification (MOC) Program.

This on-demand activity is intended for SIR to provide a comprehensive overview of what's new in IR coding in 2017 and some common coding scenarios.

As a result of participating in this activity, the learner should be able to:

  • Describe the basics of the coding process and code valuation
  • Apply to clinical scenarios the new 2017 codes for Dialysis Access procedures
  • Apply to clinical scenarios new codes for angioplasty, and basics of the new moderate Sedation codes

This course is intended to meet the educational needs of interventional radiologists, IR clinical technologists, and administrators with an interest or responsibilities for accurate coding and practice reimbursement.

Faculty

Moderators 
Timothy L. Swan, MD, FSIR, FACR
Stephanie Dybul, MBA, RT(R)(VI), CIRCC

Speakers 
Katharine L. Krol, MD, FSIR
C. Matthew Haukins, MD
Waleska Pabon-Ramos, MD, MPH
Ammar Sarwar, MD

Faculty Disclosures

The faculty have no relevant financial relationships to disclose. 

CME Accreditation 
This activity has been planned and implemented in accordance with the Essentials and Standards of the Accreditation Council for Continuing Medical Education (ACCME). The Society of Interventional Radiology (SIR) is accredited by the ACCME to provide medical education for physicians.

The Society of Interventional Radiology designates this live activity for a maximum of 1 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

SAM Accreditation 
This program is approved for 1.0 self-assessment (SAM) credits by the Society of Interventional Radiology (SIR) – Approval Date: January 23, 2017. SIR is awarded Deemed Status by the American Board of Radiology (ABR). This educational activity meets the criteria for SA-CME toward the purpose of fulfilling requirements in the ABR Maintenance of Certification (MOC) Program.

Managing acute arterial occlusion remains a challenge and in the correct setting, thrombolysis, PTA and stenting are excellent treatment options. Despite these advances, the morbidity, mortality, and limb loss rates from acute lower extremity ischemia remain high, and therefore, early diagnosis and rapid treatment are essential to salvage the extremity. The nuts and bolts of patient evaluation, understanding etiologies of and determining appropriate management will be reviewed here.

SIR members $25
Standard $100

Upon completion of this Webinar, participants should be able to:

  • Discuss pre-procedure patient evaluation and minimize potential complications.
  • Identify appropriate candidates and best treatment options based on presentation and anatomy.
  • Review technical pearls that can lead to improved clinical outcomes.

This enduring activity is designed to meet the educational needs of interventional radiologists and other physicians at all levels with special interest in acute arterial thrombosis. 

Coordinator
Mark J. Garcia, MD, FSIR, EnvoVascular Consultants 

Speakers
Parag J. Patel, MD, MS, Medical College of Wisconsin 
Derek Mittleider, MD, Vascular & Interventional Physicians, Spectrum Medical Group 
Daniel A. Leung, MD, FSIR, Christiana Care Healthy System
James F. Benenati, MD, FSIR, Baptist Cardiac & Vascular Institute

The Society of Interventional Radiology (SIR) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide medical education for physicians.

SIR designates this enduring material for a maximum of 1.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This on-demand activity will use hepatic embolization as the basis for discussion; speakers will provide their approaches – bland embolization, TACE, DEB-TACE, and/or radioembolization in patients with a variety of primary and secondary malignancies. Patients will be followed from consult through procedure to follow up. 

SIR members $25
Standard $100

Upon completion of this enduring activity, the participant will be able to: 

  • Demonstrate the factors that must be considered in choosing the most appropriate embolic
  • Describe procedural techniques specific to bland-, chemo-, and radio-embolics
  • Explain potential advantages and disadvantages of available embolics vis-a-vis the treatment of patients with hepatic malignancies

This program is designed to meet the educational needs of interventional radiologists, diagnostic radiologists, and other physicians at all levels with special interest in embolization treatments.

Coordinators
Jafar Golzarian, MD, FSIR, University of Minnesota
Matthew S. Johnson, MD, FSIR

Speakers
Matthew S. Johnson, MD, FSIR
Gregory J. Nadolski, MD
Jafar Golzarian, MD, FSIR
Ron C. Gaba, MD, FSIR

The Society of Interventional Radiology (SIR) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide medical education for physicians.

SIR designates this enduring material for a maximum of 1.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This session will discuss treatment strategies and clinical indications for the superficial femoral and popliteal arteries. This distribution of peripheral vascular disease offers a number of treatment alternatives which have impact on cost, reimbursement and both long and short term patency. The rapidly evolving technology being developed and currently in use will be discussed.

SIR members $25
Standard $100

Upon completion of this Webinar, participants should be able to:

  • Discuss treatment strategies and clinical indications for the superficial femoral and popliteal arteries
  • Explain the treatment alternatives and how they may have impact on cost, reimbursement and both long and short term patency
  • Describe the rapidly evolving technology that is currently in use and those being developed

This enduring activity is designed to meet the educational needs of interventional radiologists and other physicians at all levels with special interest in infra-inguinal disease.

Coordinator
Michael J. Miller, Jr., MD, Duke University Medical Center

Speakers
Bjorn I. Engstrom, MD
Charles Gilliland, MD, Emory University School of Medicine
Mark L. Lessne, MD, Vascular & Interventional Specialists of Charlotte Radiology 
Shawn Sarin, MD, FSIR, George Washington University 
Robert A. Lookstein, MD, FSIR, Mount Sinai Hospital

The Society of Interventional Radiology (SIR) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide medical education for physicians.

SIR designates this enduring material for a maximum of 1.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Originally presented at the 2016 SIR Annual Scientific Meeting, this comprehensive case-based review on-demand activity will include expert faculty presented cases covering the key overlapping domains of interventional radiology: imaging, interventions (arterial, venous, nonvascular) and clinical care. In this activity, participants will complete a post test of a series of case-related questions and earn self-assessment module (SAM) credits toward American Board of Radiology (ABR) Maintenance of Certification (MOC). 

SIR members $150.00
Standard $300.00

Upon completion of this enduring activity, participants should be able to:

  • Describe the role that imaging plays in procedural planning for a broad range of percutaneous interventions.
  • Explain the periprocedural care and decision-making for patients referred for possible percutaneous interventions.
  • Discuss the current evidence to support the decision making for percutaneous interventions.
  • Discuss technical aspects of the involved image guided interventions.

This program is designed to meet the educational needs of interventional radiologists, oncologists, diagnostic radiologists and other physicians with special interest in IR; nurses at all levels; radiology technologists at all levels; and physician assistants.

Clinical Care in IR

  • Gregory J. Dubel, MD, FSIR, Alpert School of Medicine of Brown University 
  • Van T. Nguyen, MD, Warren Alpert Medical School of Brown University 

Arterial Intervention

  • Derek Mittleider, MD, Vascular & Interventional Physicians, Spectrum Medical Group
  • Sarah B. White, MD, Medical College of Wisconsin

Venous Intervention

  • Seung Kwon Kim, MD, Mallinckrodt Institute of Radiology Washington University in St Louis
  • Akhilesh K. Sista, MD
  • Naganathan B. Mani, MD, Mallinckrodt Institute of Radiology 

Non-Vascular Intervention

  • Lynn Brody, MD, FSIR, Memorial Sloan-Kettering Cancer Center
  • Stephen L. Ferrara, MD, FSIR

The Society of Interventional Radiology (SIR) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide medical education for physicians.Credit Information 

SIR designates this enduring material for a maximum of 3.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

  • SIRmeeting
  • SIR Connect
  • SIR DVL
  • SIR SA-CME
  • SIRCloud
  • APDIR

© Copyright 2017 The Society of Interventional Radiology. All rights reserved.